Skip to main content
Clinical Trials/DRKS00013184
DRKS00013184
Completed
未知

Prospective, controlled interventional study to determine the benefit of a clinical pharmacist on a German intensive care unit

Gesundheit Nordhessen Holding AG0 sites336 target enrollmentDecember 7, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
medication errors
Sponsor
Gesundheit Nordhessen Holding AG
Enrollment
336
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 7, 2017
End Date
April 28, 2017
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Gesundheit Nordhessen Holding AG

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18 years and older were included in the study population if they stayed on the ICU for 24 hours or longer (work days only). If a discharged patient (that had not recieved any pharmaceutical care in the meantime) returned within 72 hours, the patient was still a part of the study population.

Exclusion Criteria

  • lack of documentation
  • \- if less than 24h of the stay are documented in the patients’ medical records
  • \- if more than 5% of the medical records are missing
  • patients only admitted for monitoring
  • palliative patients

Outcomes

Primary Outcomes

Not specified

Similar Trials